Growing health concerns from perfluoroalkyl substances: public health perspectives and clinical implications
- PMID: 32172278
- DOI: 10.1038/s41390-020-0836-3
Growing health concerns from perfluoroalkyl substances: public health perspectives and clinical implications
Comment on
-
Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.Pediatr Res. 2020 May;87(6):1093-1099. doi: 10.1038/s41390-019-0720-1. Epub 2019 Dec 13. Pediatr Res. 2020. PMID: 31835271 Free PMC article.
References
-
- Kingsley, S. L. et al. Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood. Environ. Res. 165, 247–257 (2018). - DOI
-
- Ye, X. et al. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013−2014. Int. J. Hyg. Environ. Health 221, 9–16 (2017). - DOI
-
- Blencowe, H. et al. Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010. Pediatr. Res. 74(suppl 1), 17–34 (2013). - DOI
-
- Bach, C. C. et al. Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review. Crit. Rev. Toxicol. 45, 53–67 (2015). - DOI
-
- Manzano-Salgado, C. B. et al. Prenatal exposure to perfluoroalkyl substances and cardiometabolic risk in children from the Spanish INMA birth cohort study. Environ. Health Perspect. 125, 097018 (2017). - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
